Chief Executive Officer @ Vivocore Inc. (January 2022 - Present)
Chief Executive Officer @ (September 2008 - December 2011)
CEO @ Maccine (May 2006 - September 2008)
Director of Business Projects @ (January 2005 - January 2006)
Head of GSK Singapore Center for Cognitive and Neurodegenerative Disease @ (January 2004 - January 2005)
Director of Neurocell Science @ (January 2002 - January 2004)
Associate Director @ Synaptic Pharmaceutical Corp (January 2001 - January 2002)
Senior Team Leader @ (January 1998 - January 2001)
Research Scientist @ Merck Sharp and Dohme (January 1996 - January 1998)
Mark Duxon Education
University of Nottingham
Doctor of Philosophy (PhD) (Neuropharmacology)
1993-1996
University of Nottingham
Bachelor of Science (BSc) (Molecular Biology)
1990-1993
Mark Duxon Skills
Animal Models
Biochemistry
Biomarkers
Biopharmaceuticals
Biotechnology
CRO
Cell
Cell Biology
Clinical Development
Clinical Trials
Commercialization
Drug Development
Drug Discovery
GLP
Genetics
Genomics
Immunology
In Vitro
In Vivo
Life Sciences
Lifesciences
Molecular Biology
Neuroscience
Pharmaceutical Industry
Pharmacology
R
R&D
Research
Research and Development (R&D)
Science
Technology Transfer
Translational Research
Mark Duxon Summary
Mark Duxon, based in London, GB, is currently a CEO at Transpharmation Ltd. Mark Duxon brings experience from previous roles at InterVivo Solutions, Vivocore Inc., Porsolt and Maccine. Mark Duxon holds a 1993 - 1996 Doctor of Philosophy (PhD) in Neuropharmacology @ University of Nottingham. With a robust skill set that includes Animal Models, Biochemistry, Biomarkers, Biopharmaceuticals, Biotechnology and more. Mark Duxon has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Duxon?
Find contact details for 700 million professionals.